EQS-News: MorphoSys AG / Key word: Annual Report
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
13.03.2024 / 21:01.
- After obtaining all regulatory approvals, Grifols has closed the acquisition of 100% of the share capital of Tiancheng (Germany) Pharmaceutical Holdings AG,.
Grifols completes the acquisition of Biotest: a strategic and transformational transaction to accelerate growth and innovation apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.